Vaishali Sanchorawala

96PUBLICATIONS
173CO-AUTHORS
AutoimmunityAnaesthesiologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (96)

|Jul 29, 2026
1F10, a λ Light Chain Amyloid-Specific Monoclonal Antibody for Targeted Therapy of AL Amyloidosis.

|Jul 21, 2026
Efficacy and Safety of BCMA-Targeted Therapies in Relapsed or Refractory AL Amyloidosis: A Descriptive Pooled Analysis.

|Jun 22, 2026
Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020.

|May 29, 2026
Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.

|May 12, 2026
Daratumumab-Bortezomib-Cyclophosphamide-Dexamethasone in Newly Diagnosed Amyloidosis: ANDROMEDA Final Survival Analysis.

|Apr 17, 2026
Evaluating AL-ISS within a BNP-based model for AL amyloidosis in the daratumumab era.

Pageof 16

Frequent Collaborators

19 joint publications

Andrew Staron

14 joint publications

J Mark Sloan

12 joint publications

Angela Dispenzieri

12 joint publications

Shayna Sarosiek